Daily News Round Up
Tuesday, 17 Jun 2025
- Geopolitical Risks Remain Elevated but Markets Show Resilience: Despite escalating tensions between Israel and Iran, equity markets demonstrated surprising resilience on Monday, with major indices rebounding as hopes for de-escalation emerged. Oil prices saw an initial spike but quickly retreated, suggesting the immediate threat to supply hasn’t materialized. While the situation remains volatile, investor reaction indicates a degree of normalization around geopolitical risk, at least for now. (Reuters), (Seeking Alpha), (Investopedia)
- U.S. Household Equity Exposure is at Record Highs, Supporting Market Demand: U.S. households are poised to be significant net buyers of equities in 2025, with allocations reaching a record 49% of financial assets. This, coupled with strong retail trading volumes (+$20B in the last three months) and elevated savings rates, provides a fundamental underpin for continued market gains, especially as Goldman Sachs expect this trend to continue as long as economic conditions hold. Households are projected to purchase an estimated $425 billion in stocks this year. (FMP), (Barrons)
- Central Bank Policy Meetings Loom Large, With Rate Cuts Still Uncertain: The Federal Reserve is expected to hold rates steady this week, but the broader context of multiple central bank meetings (Switzerland, Sweden, U.K., Norway) and upcoming economic data (U.S. retail sales, Chinese industrial production) will heavily influence market direction. Investors anticipate clues about the timing of potential rate cuts, with expectations for a 100 basis point reduction by the end of 2024 potentially bolstering equity valuations. (FMP), (WSJ), (NYTimes)
- Corporate Earnings Paint a Mixed Picture with Sector-Specific Nuances: Recent earnings reports reveal a divergent landscape. Adobe Inc. raised its full-year guidance, driven by AI demand, while Lennar Corporation saw a miss on EPS despite revenue beating expectations and guidance was lowered. Sarepta Therapeutics faced significant stock decline following a second patient death in a gene therapy trial. These results underscore the importance of stock-specific analysis and highlight the sensitivity of certain sectors (e.g., biotech) to adverse events. (FMP), (FMP), (FMP)
- Trade and International Relations Show Signs of Improvement but Remain Complex: The completion of a U.S.-UK trade deal and easing of tensions amidst US-China trade discussions, combined with increased Asian hedge fund investment, are positive signals. However, potential Canadian retaliation against U.S. tariffs and ongoing geopolitical uncertainties inject complexity. Nvidia’s attendance at the China trade expo showcases a strategic effort to engage despite restrictions. (Reuters), (FMP), (Reuters)
What happened yesterday?
Macro
Economic Growth: U.S. households are projected to be the second-largest net buyers of equities this year, purchasing an estimated $425 billion, behind corporations at $675 billion. Households directly hold 38% of U.S. equities, with total allocations reaching 49% of financial assets—a record high surpassing the 2000 dot-com peak, compared to 13% in Japan and 10% in the Euro Area. U.S. equities have rallied 21% from April lows, with retail trading contributing $20 billion in net buying over the past three months. Savings remain elevated, and unemployment is near historic lows, supporting continued household demand. 401(k) contributions drive roughly $500 billion in annual equity demand, with average equity allocations rising to 71% in 2022 from 66% in 2013. (FMP)
Economic Growth: U.S. retail investors should continue to buoy the S&P 500 as long as hiring and household balance sheets remain healthy and interest rates remain low, forecast Goldman Sachs. (Barrons)
Geopolitics: Asian stock markets were subdued Tuesday amid rising U.S.-Iran tensions, with Donald Trump calling for evacuation of Tehran and continued airstrikes between Israel and Iran marking the fifth day of conflict. S&P 500 Futures decreased by 0.4% in Asian trade. The Nikkei 225 rose 0.6%, and the TOPIX index gained 0.4%. The Bank of Japan maintained interest rates at 0.5% and will continue government bond purchases through 2026, reducing bond buying by 200 billion yen per quarter starting April 2026 (compared to the current 400 billion yen pace). Investors await a speech by BOJ Governor Kazuo Ueda and the Federal Reserve interest rate decision on Wednesday. (FMP)
Geopolitics: Geopolitical tensions between Israel and Iran are escalating, with Iran ruling out a ceasefire and Israeli airstrikes targeting nuclear sites. Brent crude rose to $74.53 and WTI crude to $71.64, increasing over $4 earlier on Tuesday, amid fears of a wider regional war. The G7 summit in Canada will address the Israel-Iran conflict and trade disputes, with Canada prepared to retaliate against U.S. steel and aluminum tariffs. The Federal Reserve is expected to hold rates at 4.25%-4.5% on Wednesday, with rate decisions also pending from Switzerland, Sweden, the U.K., and Norway. U.S. retail sales for May are forecast to decline 0.6% monthly, reversing April’s 0.1% growth, though consumer sentiment rebounded in June. China’s industrial production rose 5.8% year-over-year (YoY), below estimates of 5.9% and down from April’s 6.1%, while Chinese retail sales exceeded expectations. (FMP)
Geopolitics: Oil prices declined on Monday, reversing earlier gains following an escalation of the Israel-Iran conflict. Brent crude dropped 1.3% to $73.32 a barrel, and WTI crude decreased 1.2% to $70.46. This followed a surge of over $4 earlier in the day and a 7% increase on Friday – the largest one-day rally since January. The conflict involved Israeli strikes on Iranian nuclear sites and Iranian missile attacks on Israeli cities including Tel Aviv. Despite tensions, there has been no reported damage to oil infrastructure or export routes. Iran is the third-largest OPEC producer, with 3.3 million barrels per day (bpd) production and approximately 1.7 million bpd in exports. OPEC possesses 5 million bpd of spare capacity, which could buffer against potential supply disruptions. Approximately a third of global seaborne oil trade passes through the Strait of Hormuz. (FMP)
Geopolitics: Markets today face geopolitical headwinds as Israel-Iran tensions escalate, with retail sales and industrial data set to guide U.S. trading ahead of the Fed. (FXEmpire)
Geopolitics: A significant escalation in the Israel-Iran conflict led to higher oil and gold prices as investors immediately reacted to the news. It’s important for investors to remember that markets have historically shown resilience in the face of regional conflicts. (Seeking Alpha)
Geopolitics: U.S. stocks rose Monday on news that Iran is reportedly seeking a ceasefire with Israel. Despite the Israel-Iran conflict entering its fourth day, both safe-haven assets and oil prices dipped Monday. (CNBC)
Geopolitics: Investor sentiment and risk appetite rebounded sharply on Monday as fears around the Israel-Iran conflict subsided, shifting the spotlight away from geopolitical risk and back towards this week’s raft of central bank policy meetings (Reuters)
Geopolitics: Following last Friday’s oil price surge in the wake of Israel’s airstrikes on Iran, the oil markets have begun to settle given a sense that a broader regional conflict may be avoidable. But any notion of calm could be premature. (Forbes)
Geopolitics: The escalating conflict between Israel and Iran has heightened fears of a potential World War III, injecting uncertainty into global markets. (Finbold)
Geopolitics: Stocks rose and oil prices retreated on Monday as investors shrugged off the continuation of hostilities between Israel and Iran over the weekend. (Investopedia)
Geopolitics: The S&P 500 was on track for a winning week. Until Friday, 13 June 2025, when geopolitical events took over the headlines for market-moving news. (Seeking Alpha)
Geopolitics: The Iran-Israel conflict and equity markets are now in sharp focus. As direct strikes escalated in June 2025, global financial markets responded immediately. (Seeking Alpha)
Geopolitics: Stocks rallied on Monday on reports that Iran is seeking talk to end its war with Israel, easing fears that the conflict could spiral into a broader regional war. The Dow Jones Industrial Average jumped 463 points, or 1.10%, to 42,660.98. (New York Post)
Inflation: The equity markets were slightly positive for the week, through Thursday. Then hostilities broke out in the Middle East. (Forbes)
Interest Rates: U.S. stock index futures rebounded Monday, with Dow Jones Futures up 145 points (+0.4%), S&P 500 Futures up 27 points (+0.5%), and Nasdaq 100 Futures up 113 points (+0.5%) as of 05:25 ET (09:25 GMT). This follows Friday’s market losses: S&P 500 (-1.1%), Nasdaq Composite (-1.3%), and Dow (-1.8%). Investors are positioning ahead of Wednesday’s FOMC rate announcement. Geopolitical tensions escalated over the weekend with Israel and Iran exchanging missile strikes, prompting civilians near Iran’s nuclear sites to evacuate. At the G7 summit in Canada this week, leaders will issue a joint appeal for de-escalation and discuss balancing diplomacy with defense regarding Iran’s nuclear ambitions. Canadian PM Carney indicated potential retaliation against U.S. steel and aluminum levies if Washington doesn’t adjust tariffs. (FMP)
Interest Rates: The S&P 500 closed higher on Monday, with the Dow Jones Industrial Average gaining 317 points (0.8%), the S&P 500 rising 1%, and the NASDAQ Composite climbing 1.4%. Oil prices fell due to easing geopolitical risk following reports of potential ceasefire negotiations between Iran and Israel, though Iran denied these claims. The Federal Reserve’s two-day policy meeting begins Tuesday, with expectations of rates holding steady around 4.5%, but investors anticipate hints of future rate cuts after a 100 basis point reduction in 2024. The G7 summit in Canada may be contentious due to potential retaliatory measures from Canada regarding U.S. tariffs. U.S. manufacturing data is due later Monday. Roku shares surged due to a partnership with Amazon Ads, United States Steel gained following approval of its merger with Nippon Steel, and Sarepta Therapeutics shares tumbled after a second patient death related to its Elevidys gene therapy. (FMP)
Interest Rates: The Bank of Japan (BOJ) maintained its benchmark interest rate at 0.5%, following a 25 basis point hike in January, marking the third consecutive policy meeting without a change. Bond purchases will be reduced by 200 billion yen per quarter starting in April 2026, down from the current 400 billion yen pace. An interim review of this tapering plan is scheduled for June 2026. The BOJ cited a moderately recovering economy experiencing “some weakness,” and downgraded both GDP and inflation forecasts earlier this year. The policy aims to avoid market disruptions while normalizing policy after years of stimulus, balancing fragile domestic demand with global slowdown and managing bond market stability. (FMP)
Interest Rates: Central-bank officials, who meet this week, are in a holding pattern as they wait to see what worsens first: inflation or the labor market. (WSJ)
Interest Rates: The central bank is set to hold interest rates steady for its fourth straight meeting, a pause that could be extended through the summer. (NYTimes)
Interest Rates: Throughout 2024, everyone from Wall Street analysts to everyday borrowers buzzed with anticipation over interest rate cuts. Lower rates usually mean cheaper loans, friendlier mortgage terms, and a nice tailwind for stocks and businesses alike. (Zacks Investment Research)
International relations: Global hedge funds experienced their largest jump in Asian trading volumes in over five years between June 6 and June 12. Bullish positions in Asia reached highs not seen since September 2024. The MSCI Asia-Pacific Index is up 2.5% in June and 24% since April 7. Developed Asia’s share in hedge-fund portfolios increased to 9%, placing it in the 94th percentile over the past five years, driven by U.S.-China trade talks, the South Korean election, and a de-dollarization trend. Japan, Hong Kong, Taiwan, and India saw the largest net buying inflows, while onshore Chinese equities were the primary target for short selling. (FMP)
International relations: A recent survey by the World Gold Council (WGC), conducted between February 25 and May 20, involving 73 central banks, reveals a significant shift in global reserve strategies. 76% of respondents expect to increase their gold holdings over the next five years, up from 69% in 2023, with 95% anticipating growth in global central bank gold reserves in the next 12 months—a record high from 81% last year. Nearly three-quarters of respondents foresee a drop in dollar holdings, compared to 62% the previous year. Gold reached a record high of $3,500.05/oz in April, representing a 95% surge since the start of the Russia-Ukraine war in 2022. Central banks have acquired over 1,000 metric tons of gold annually for the last three years, a sharp increase from the 400–500 ton average of the previous decade. (FMP)
International relations: SALT divides GOP lawmakers, U.S., U.K. show off signed trade deal, Trump family business gets into mobile phones, and more news to start your day. (Barrons)
International relations: Trump signed a G-7 statement calling for peace in the Middle East, before leaving the meeting in Canada early (WSJ)
International relations: The UK-US trade deal has been signed and is “done”, US President Donald Trump has said as he met Sir Keir Starmer at the G7 summit. (Skynews)
International relations: Dow Jones retook a key level on a sign the Israel-Iran conflict may de-escalate. (Investors Business Daily)
International relations: U.S. President Donald Trump and British Prime Minister Keir Starmer on Monday said they had finalized a trade deal reached between the two allies last month. (Reuters)
International relations: U.S. President Donald Trump is expected to sign a proclamation finalizing the terms of a U.S.-British trade deal agreed last month in coming days, three sources familiar with the matter said on Monday. (Reuters)
International relations: The agreement, which focused on the sharing of information, will allow SEC regulators to review client documents (Barrons)
International relations: The development comes as President Trump and other world leaders prepare to meet in Canada this week for the annual G-7 summit. (New York Post)
Market Sentiment: Technology stocks, as tracked by the Nasdaq 100, have returned to a critical valuation level not seen since the height of the Dot-com bubble burst, this time in relation to the M2 money supply. (Finbold)
Market Sentiment: Dow industrials rebound, oil falls and investors look ahead to G-7 summit, Fed meeting. (WSJ)
Market Sentiment: Despite all the “Sell America” talk, the dominating impulse in more recent weeks has been “Buy America Back”. Equity markets are up, credit spreads down and Treasury yields have calmed. (Seeking Alpha)
Policy: Is inflation going to speed up again? Are businesses going to stop hiring? (Market Watch)
Trade: U.S. President Donald Trump said on Monday a new economic deal with Canada was possible but stressed tariffs had to play a role, a position that the Canadian government strongly opposes. (Reuters)
Industry
Energy: Solar stocks such as SolarEdge and First Solar plunged Monday night after the Senate budget bill would phase out solar and wind tax credits by 2028. (Investors Business Daily)
Retail: Big-box retailer has struck a deal with lenders to eliminate almost all of its nearly $2 billion in funded debt and has secured around $200 million in capital to support its operations. (WSJ)
Semiconductors: U.S. chipmaker Nvidia will attend the China International Supply Chain Expo in Beijing from July 16-20. The expo will feature over 230 new participants, with U.S. companies forming the largest foreign presence, showing a 15% increase in participation compared to last year. Nvidia’s attendance comes amid shrinking market share in China due to U.S. export restrictions and increased local competition, as well as tighter controls from the Biden administration. The event is not typically for high-value deals but serves as a platform for foreign firms to demonstrate engagement with China’s industrial ecosystem. (FMP)
Corporate
Adobe Inc: Adobe Inc. reported Q2 revenue of $5.87 billion, exceeding the consensus estimate of $5.80 billion. The company lifted its fiscal 2025 guidance, now projecting adjusted EPS of $20.50-$20.70 (previously $20.20-$20.50) and revenue of $23.50-$23.60 billion (previously $23.30-$23.55 billion). The Digital Media segment forecast was increased to $17.45-$17.50 billion, up from $17.25-$17.40 billion. For Q3, Adobe anticipates adjusted EPS of $5.15-$5.20 and revenue of $5.875-$5.925 billion, both slightly above the consensus estimates of $5.11 and $5.88 billion, respectively. Annual recurring revenues from AI services are projected to surpass the $250 million target, and the company expects double-digit growth across its business. (FMP)
AIB Group: The Irish government said on Tuesday that it had sold its remaining shares in AIB Group , one of the country’s two dominant lenders it effectively nationalised 15 years ago as part of the euro zone’s biggest state rescue. (Reuters)
AIB Group: The Irish government on Monday launched the sale of its remaining shares in AIB Group , one of the country’s two dominant lenders it effectively nationalised 15 years ago, Finance Minister Paschal Donohoe said. (Reuters)
Apple Inc: UBS maintains a Neutral rating on Apple Inc. (NASDAQ:AAPL) with a $210 price target, citing a likely short-lived boost in iPhone sales. Global iPhone sell-through for April and May increased by mid-teens percentage year-over-year, mirroring April’s 14% increase, reportedly driven by concerns over potential U.S. tariffs. iPhone sell-through is currently estimated to be approximately 4 million units higher than the same period last year. The June quarter typically averages around 45 million iPhone units, and UBS anticipates a cooling in demand due to underwhelming announcements at WWDC and subdued purchase intent in their latest Evidence Lab survey. (FMP)
DoubleVerify Holdings, Inc: DoubleVerify Holdings, Inc. (NYSE: DV) is facing legal scrutiny regarding potential violations of federal securities laws, impacting investors who lost over $75,000 between November 10, 2023, and February 27, 2025. The investigation concerns misleading statements and omissions related to the shift of customer ad spending from open exchanges to closed platforms like Meta and Amazon, which exposed limitations in DoubleVerify’s technology and increased development costs. Competitors were allegedly better positioned to integrate AI, impacting DoubleVerify’s profitability. Additionally, accusations involve overbilling customers for bot traffic and misleading risk disclosures. On February 27, 2025, DoubleVerify reported lower-than-expected fourth-quarter 2024 sales and earnings, causing a 36% stock price drop from $21.73 to $13.90 per share. Despite this, BMO Capital maintained an “Outperform” rating on June 12, 2025, raising the price target from $25 to $26. Currently, DoubleVerify’s stock is priced at $14.66, with a market capitalization of approximately $2.38 billion, experiencing a 1.10% increase today with a trading volume of 1,893,773 shares, and a 52-week range of $23.11 to $11.52. (FMP)
Lennar Corporation: Lennar Corporation reported second-quarter results on Monday, with adjusted EPS of $1.90, missing the $1.94 consensus, and revenue of $8.38 billion, exceeding the $8.18 billion consensus. Shares declined 1.2% in after-hours trading. Home deliveries totaled 20,131, a 2% year-over-year (YoY) increase, while new orders reached 22,601, a 6% YoY increase. The average sales price decreased by 9% to $389,000 from $426,000. Gross margin was 17.8% (18.0% ex-purchase accounting), down from 22.6% in Q2 2024, with Q3 margin guidance around 18%. New order guidance for Q3 is 22,000-23,000 homes, below the 23,674 consensus. Lennar repurchased 4.7 million shares for $517 million and ended Q2 with $5.4 billion in liquidity and an 11.0% homebuilding debt-to-capital ratio. (FMP)
LGI Homes Inc: S&P Global Ratings downgraded LGI Homes Inc. (NASDAQ: LGIH) to B+ from BB- on June 16, 2025, assigning a negative outlook. S&P forecasts sales absorption to decline to 3.2 home sales per community per month, down from 4.0 in 2024. Average selling prices and gross margins are expected to remain flat with up to 200 bps of margin compression. Adjusted Debt/EBITDA is projected at 5.5x-6x at year-end 2025, improving to 5x by late 2026, with Interest Coverage at 2x-2.5x. LGI Homes has $302.4 million drawn on its $1.1825 billion unsecured revolver, maturing in April 2029. The senior unsecured notes maintain a BB- rating and the expected recovery rating was upgraded to 2 (70%-90% recovery in default). Further downgrades are possible if Debt/EBITDA remains ≥ 5x or Interest Coverage falls below 2x within the next 12 months. (FMP)
Oracle Inc: Oracle’s shares increased in after-hours trading following fiscal Q4 results and a raised FY26 revenue target. Q4 adjusted EPS was $1.70, exceeding the expected $1.64, while revenue reached $15.9 billion, above the consensus estimate of $15.58 billion. Oracle Cloud Infrastructure (OCI) revenue grew by 62% year-over-year (YoY), and remaining performance obligations rose to $138 billion, a 41% YoY increase. CEO Safra Catz projected total revenue of at least $67 billion for FY26, implying 16.7% annual growth, up from a previous estimate of 15%. Total cloud growth (applications + infrastructure) is expected to exceed 40%, compared to 24% in FY25. Capital expenditure levels are rising, and Oracle anticipates interim upside despite past execution challenges. (FMP)
Oxford Industries (NYSE: OXM): Oxford Industries (NYSE: OXM) reported Q1 results with EPS of $1.82, missing the estimated $1.98 by $0.16, but revenue of $393 million narrowly beat the $383.54 million consensus. The company sharply downgraded guidance for Q2 2025, projecting EPS of $1.05-$1.25 (vs. $2.20 expected) and revenue of $395M-$415M (vs. $409.4M expected). FY 2025 guidance was also lowered: EPS of $2.80-$3.20 (vs. $4.35 expected) and revenue of $1.48B-$1.52B (vs. $1.49B expected). The stock closed at $50.07, down 11.77% over the past 3 months and 50.44% over the past 12 months. Over the last 90 days, there were 0 positive and 3 negative EPS revisions. (FMP)
Oxford Industries Inc: On June 16, 2025, Chubb Thomas Caldecot III purchased 6,500 shares of Oxford Industries Inc. (NYSE:OXM) at $40.12 each, bringing his total holdings to 59,063 shares. The company reported consolidated net sales of $393 million for the first quarter of fiscal 2025 (ending May 3, 2025), a decrease from $398 million in the same period of fiscal 2024. Increased tariffs are expected to cost Oxford Industries $40 million and have led to a reduced full-year profit forecast. Currently, OXM’s stock is priced at $41.24, a 4.41% increase of $1.74, with a daily trading range of $38.77 to $41.24. Over the past year, the stock has ranged from $38.77 to $108.51, with a market capitalization of approximately $613.4 million and a trading volume of 559,662 shares. (FMP)
Roblox (NYSE:RBLX): Piper Sandler adjusted Roblox (NYSE:RBLX) to an “Overweight” grade on June 16, 2025, with an approximate stock price of $100.17. The stock currently trades at $100.33, a 3.25% increase, with daily fluctuations between $98.36 and $100.73. Over the past year, RBLX has ranged from $34.41 to $100.74. The company’s revenue has grown by 29%, outpacing Take-Two Interactive’s 5-6% outlook. Roblox’s market capitalization is approximately $68.05 billion, and its trading volume is 5.8 million shares. (FMP)
Sarepta Therapeutics: On June 15, 2025, BMO Capital downgraded Sarepta Therapeutics (NASDAQ:SRPT) from “Outperform” to “Market Perform” when the stock price was $36.18. Following the death of a second patient linked to its Elevidys gene therapy for Duchenne muscular dystrophy (DMD), Sarepta suspended its full-year financial guidance. Dosing has been halted, and ongoing trials paused. The stock price has fallen to $20.29, a 43.92% decrease. Today’s trading range is between $18.30 and $21.55. Sarepta’s market capitalization is approximately $1.99 billion, with a trading volume of 26.34 million shares. The stock previously reached a high of $173.25 over the past year. (FMP)
Sarepta Therapeutics, Inc.: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has seen its stock price plunge over 47% following a second patient death related to its ELEVIDYS treatment, leading to trial suspension and a current price of $19.91, representing a $16.27 decrease and a 44.97% decline. BMO Capital set a price target of $70 on June 15, 2025, when the stock was priced at $36.18, suggesting a potential 93.48% increase. Despite the setback, ELEVIDYS revenue increased 180% year-over-year, and overall product revenue grew by 70%. The company’s market capitalization is approximately $1.96 billion, with a daily trading volume of 30,136,821 shares. Today’s stock range was $18.30 to $21.55, compared to a 52-week high of $173.25 and a low of $18.30. (FMP)
Twilio Inc: Samad Samana from Jefferies set a price target of $132 for Twilio Inc. (NYSE:TWLO) on June 15, 2025, when the stock was trading at $113.39, representing a potential upside of approximately 16.41%. The stock’s current value is $117.03, a 3.21% increase ($3.64) with a daily trading range of $114.20 to $117.03. Over the past year, Twilio’s stock has ranged from a high of $151.95 to a low of $52.51. Twilio has experienced a 37% increase in the number of large customers in the first quarter, and its market capitalization is approximately $17.87 billion, with a daily trading volume of 801,632 shares on the NYSE. (FMP)
UroGen Pharma Ltd.: Goldman Sachs set a $16 price target for UroGen Pharma Ltd. (NASDAQ:URGN) on June 13, 2025, representing a potential 33% increase from the then-price of $12.03. Currently, URGN is trading at $13.48, a 12.01% increase ($1.45 change) from a previous price. The stock’s 52-week high is $19.01 and its low is $3.42. A class action lawsuit alleging securities fraud related to the ENVISION clinical study has been filed covering the period from July 27, 2023, to May 15, 2025, with a deadline for shareholders to join by July 28, 2025. UroGen’s current market capitalization is approximately $621.3 million, with a daily trading volume of 4.9 million shares. (FMP)
